A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2006
12/12/2006	US7147868 Antacid and laxative tablets
12/12/2006	US7147867 Making by adding granules of a hydrogel, hydroxyalkyl cellulose and water, and a mixture of drug, surfactant and mono or diglycerides to a capsule, coating with semipermeable membrane and providing an exit for controlled release
12/12/2006	US7147866 UV-absorbing lipid vesicles
12/12/2006	US7147865 Prostheses for controlled release of neurologically active compounds having a flow regulator in operable relationship with fluid in a reservoir for moving fluid to an aperture, especially electrical means external, implanted, or may be photodiodes activated by light; age-related macular degeneration
12/12/2006	US7147845 Antimicrobial silver ion complex resinates
12/12/2006	US7147844 System for stabilizing lacrimal fluid layer
12/12/2006	US7147841 Formulation of UV absorbers by incorporation in solid lipid nanoparticles
12/12/2006	US7147806 Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2342206C Microparticles
12/12/2006	CA2305394C Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
12/12/2006	CA2303339C A pharmaceutical composition for treating dysmenorrhea and premature labor
12/12/2006	CA2290531C Pharmaceutical formulation of omeprazole
12/12/2006	CA2286076C Use of 5ht3 antagonists for promoting intestinal lavage
12/12/2006	CA2242618C Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons
12/12/2006	CA2215680C Prilocaine and hydrofluorocarbon aerosol preparations
12/12/2006	CA2201598C Vaccine compositions
12/12/2006	CA2183331C Process for producing a sterile prednisolone gel
12/12/2006	CA2179294C Low molecular weight hyaluronic acid with peptide or protein
12/12/2006	CA2162670C High dose formulations of mycophenolate mofetil, mycophenolic acid and ranolazine
12/12/2006	CA2153570C Pharmaceutical composition for treating nicotine dependence
12/08/2006	WO2008073068A1 Nanoparticulate and controlled release compositions comprising cefditoren
12/08/2006	CA2612994A1 Nanoparticulate and controlled release compositions comprising cefditoren
12/07/2006	WO2006130868A1 Method for terminal sterilization of transdermal delivery devices
12/07/2006	WO2006130843A1 Modified-release composition of at least one form of venlafaxine
12/07/2006	WO2006130826A1 Method for terminal sterilization of transdermal delivery devices
12/07/2006	WO2006130177A1 Particulate-stabilized injectable pharmaceutical compositions of posaconazole
12/07/2006	WO2006130065A1 Peritoneal dialysis fluid
12/07/2006	WO2006129966A1 Manufacturing method of controlled-release tablet containing doxazocin mesylate
12/07/2006	WO2006129745A1 Skin patch
12/07/2006	WO2006129668A1 Sugar-coated pill
12/07/2006	WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution
12/07/2006	WO2006129386A1 Enteric medicinal composition for oral use
12/07/2006	WO2006129323A1 A composition to enhance the bioavailability of curcumin
12/07/2006	WO2006129320A2 Biodegradable polymers having a pre-determined chirality
12/07/2006	WO2006129167A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS
12/07/2006	WO2006129160A2 Stable aqueous oral solution of risperidone
12/07/2006	WO2006129127A1 Compositions comprising a lipid and copolymer of styrene and maleic acid
12/07/2006	WO2006129095A2 Sustained release preparations of pro-insulin c-peptide
12/07/2006	WO2006129078A1 The use of malonates or aldonates in laser imaging
12/07/2006	WO2006128981A1 Electrostatic patch for allergen screening and applicator for same
12/07/2006	WO2006128907A2 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
12/07/2006	WO2006128888A1 Use of solid lipid nanoparticles comprising cholesteryl propionate and/or cholesteryl butyrate
12/07/2006	WO2006128735A1 Anti-inflammatory preparations and their intrathecal use in the therapy of inflammatory diseases of the central nervous system
12/07/2006	WO2006128634A1 Extract of olibanum (frankincense gum) in the form of nanoparticles, and use thereof
12/07/2006	WO2006128471A2 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
12/07/2006	WO2006128469A2 Blends of inactive particles and active particles
12/07/2006	WO2006128468A1 A method of manufacturing a nicotine delivery product
12/07/2006	WO2006128272A1 Thin foam coating comprising discrete, closed-cell capsules
12/07/2006	WO2006128255A1 Method and composition for transdermal drug delivery
12/07/2006	WO2006128253A1 Delivery systems
12/07/2006	WO2006110809A3 Nanoparticulate lipase inhibitor formulations
12/07/2006	WO2006106520A3 Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
12/07/2006	WO2006105798A3 Benzimidazole formulation
12/07/2006	WO2006105482A3 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
12/07/2006	WO2006102179A3 Confection for teeth whitening and oral hygiene
12/07/2006	WO2006101972A3 Injectable compositions of nanoparticulate immunosuppressive compounds
12/07/2006	WO2006101839A3 Enhanced bimatoprost ophthalmic solution
12/07/2006	WO2006089494A9 Osmotic device containing amantadine and an osmotic salt
12/07/2006	WO2006089056A3 Apparatus and method for transdermal delivery of erythropoetin-based agents
12/07/2006	WO2006084475A3 A tablet comprising a fibrate
12/07/2006	WO2006084248A3 Compositions comprising a platinum complex, lipid, and surfactant
12/07/2006	WO2006083257A3 Drug delivery apparatus utilizing cantilever
12/07/2006	WO2006082501A3 Fast wet-massing method for the preparation of calcium-containing compositions
12/07/2006	WO2006081354A3 Lipid carrier compositions with reduced polydispersity
12/07/2006	WO2006072920A3 Tablets of stevia extract and process for their preparation
12/07/2006	WO2006033679A3 Self-assembling nanoparticle drug delivery system
12/07/2006	WO2006024357A3 Use of statistical copolymers as dispersants
12/07/2006	WO2006015358A3 Aqueous suspension of nanoscale drug particles from supercritical fluid processing
12/07/2006	WO2006005507A8 Pharmaceutical composition of piperazine derivatives
12/07/2006	WO2005115360A3 Formulations of anti-pain agents and methods of using the same
12/07/2006	WO2005107709A3 Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
12/07/2006	WO2005102272A3 Sustained-release dosage forms for cabergoline
12/07/2006	WO2005086697A3 Materials for medical implants and occlusive devices
12/07/2006	WO2005055954A3 Pharmaceutical compounding systems and methods
12/07/2006	WO2002102129A3 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
12/07/2006	US20060276744 Configuration for drug delivery systems
12/07/2006	US20060276676 Non-symmetrical gelling agent
12/07/2006	US20060276629 Purification and characterization of soluble human HLA proteins
12/07/2006	US20060276628 Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1
12/07/2006	US20060276545 Polyhydroxy phenols and their use in binding p-selectin
12/07/2006	US20060276462 Method of treating cognitive decline due to sleep deprivation and stress
12/07/2006	US20060276441 Medicaments comprising steroids and a novel anticholinergic
12/07/2006	US20060276417 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
12/07/2006	US20060275518 Method for treating infectious diseases
12/07/2006	US20060275509 Rapidly absorbing lipophilic skin compositions and uses therefor
12/07/2006	US20060275376 Microcapsules with modified release of active principles with low solubility for oral delivery
12/07/2006	US20060275375 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
12/07/2006	US20060275374 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
12/07/2006	US20060275373 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
12/07/2006	US20060275372 Nanoparticulate imatinib mesylate formulations
12/07/2006	US20060275371 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
12/07/2006	US20060275370 Method and compositions for treatment of epithelial damage
12/07/2006	US20060275369 Orally Therapeutic Plastics and Devices Formed Therefrom
12/07/2006	US20060275368 Biocompatible polymer
12/07/2006	US20060275367 Extended release formulations
12/07/2006	US20060275366 Controlled-release formulation
12/07/2006	US20060275365 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
12/07/2006	US20060275364 Flexible Solid Dosage Forms and Methods of Making and Using the Same
12/07/2006	US20060275363 Stable granulates containing s-adenosylmethionine and process for preparation thereof

1 ... 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 ... 2991